Historically, non-seminomatous germ cell tumor (NSGCT) has been considered a radio-resistant disease, excluding radiotherapy (RT) from curative strategies. However, case series exploring the use of radiation treatment in this setting are often outdated, and prospective ongoing studies testing new radiotherapeutic approaches in NSGCT are lacking. Considering that tremendous advances in radiotherapy technology have enabled improved precision in RT delivery as well as dose escalation while decreasing treatment-related morbidity, we overviewed the currently available literature to explore the radiobiological basis, the technical issues, and potential strategies for implementation of RT in the management of this clinical entity. The purpose of the present overview is to provide insight for future research in this unexplored scenario. In summary, the biological rationale for RT use and potential implementation with systemic therapies exist, especially considering the advantage of new technologies, which were unavailable in the era of early literature reports. The NSGCT radioresistance paradigm could be based only on the fact that effective treatment schedules were simply undeliverable with older RT techniques due to toxicity issues, but the availability of actual techniques may prompt further exploration to offer treatment alternatives to these patients. Ongoing trials on this issue are lacking, but potential areas of research are platinum-refractory disease and consolidation therapy for residual masses after PST.

Francolini, G., Trodella, L., Marvaso, G., Matrone, F., Nicosia, L., Timon, G., et al. (2021). Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26(10), 1777-1783 [10.1007/s10147-021-01989-7].

Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario

Arcangeli S.
Ultimo
2021

Abstract

Historically, non-seminomatous germ cell tumor (NSGCT) has been considered a radio-resistant disease, excluding radiotherapy (RT) from curative strategies. However, case series exploring the use of radiation treatment in this setting are often outdated, and prospective ongoing studies testing new radiotherapeutic approaches in NSGCT are lacking. Considering that tremendous advances in radiotherapy technology have enabled improved precision in RT delivery as well as dose escalation while decreasing treatment-related morbidity, we overviewed the currently available literature to explore the radiobiological basis, the technical issues, and potential strategies for implementation of RT in the management of this clinical entity. The purpose of the present overview is to provide insight for future research in this unexplored scenario. In summary, the biological rationale for RT use and potential implementation with systemic therapies exist, especially considering the advantage of new technologies, which were unavailable in the era of early literature reports. The NSGCT radioresistance paradigm could be based only on the fact that effective treatment schedules were simply undeliverable with older RT techniques due to toxicity issues, but the availability of actual techniques may prompt further exploration to offer treatment alternatives to these patients. Ongoing trials on this issue are lacking, but potential areas of research are platinum-refractory disease and consolidation therapy for residual masses after PST.
Articolo in rivista - Articolo scientifico
Germ cell tumors; Non-seminomatous; Radiobiology; Radiotherapy;
English
1777
1783
7
Francolini, G., Trodella, L., Marvaso, G., Matrone, F., Nicosia, L., Timon, G., et al. (2021). Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 26(10), 1777-1783 [10.1007/s10147-021-01989-7].
Francolini, G; Trodella, L; Marvaso, G; Matrone, F; Nicosia, L; Timon, G; Ognibene, L; Vinciguerra, A; Franzese, C; Borghetti, P; Arcangeli, S
File in questo prodotto:
File Dimensione Formato  
Francolini2021_Article_RadiotherapyRoleInNon-seminoma.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 574.89 kB
Formato Adobe PDF
574.89 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/353550
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact